The Federal Trade Commission and the Georgia Attorney General's Office have banned three Georgia companies for making false claims about their stem cell therapy to treat ailments, ordering them to pay $5.155 million in penalties.
The defendants marketed their treatments as superior alternatives to proven medical interventions while deceptively training healthcare professionals on how to sell their unproven stem cell therapy through baseless claims.
Collection
[
|
...
]